NASH may soon become most common liver transplant etiology

Results of a recent study showed that nonalcoholic steatohepatitis was the most rapidly growing cause of hepatocellular carcinoma among U.S. patients listed for liver transplantation.

“The prevalence of HCC seems to be growing at a significantly higher pace for the waitlisted patients with NASH as compared to the other common causes of chronic liver disease,” Zobair M. Younossi, MD, from the Inova Fairfax Hospital in Virginia, and colleagues wrote. “It is plausible that patients with NASH may actually present late in the course of their disease with more advanced liver disease and higher stage HCC, both of which can potentially affect their status on the transplant list and their post-LT outcomes.”

Click here for the full article.


Our site uses cookies or similar technologies to recognise your repeated visits and preferences for us to deliver an optimal browsing experience. Please remember to read our privacy statement.

By clicking on "I Accept" or "X" to continue your browsing on this site, you consent to the use of the cookies. To find out how you can disable cookies on your device, please click here.

I Accept